Accès à distance ? S'identifier sur le proxy UCLouvain
Severe acute cardiomyopathy associated with venlafaxine overdose and possible role of CYP2D6 and CYP2C19 polymorphisms.
Primary tabs
- Howell C., Wilson A. D., Waring W. S., Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases, 10.1111/j.1365-2125.2007.02849.x
- Isbister Geoffrey K., Electrocardiogram changes and arrhythmias in venlafaxine overdose, 10.1111/j.1365-2125.2009.03382.x
- Mazur Joseph E., Doty John D., Krygiel Ashley S., Fatality Related to a 30-g Venlafaxine Overdose, 10.1592/phco.23.15.1668.31951
- Höjer Jonas, Hulting Johan, Salmonson Heléne, Fatal cardiotoxicity induced by venlafaxine overdosage, 10.1080/15563650701358755
- Fangio Pascal, De Jonghe Bernard, Appéré-De-Vecchi Corinne, Lachérade Jean-Claude, Terville Jean-Pierre, Outin Hervé, Dagorn Joël, Acute heart failure associated with venlafaxine poisoning, 10.1016/j.ajem.2006.08.007
- Khalifa M, J Pharmacol Exp Ther, 291, 280 (1999)
- Partridge Samuel J., MacIver David H., Solanki Tarun, A Depressed Myocardium, 10.1081/clt-100100957
- Christoph Marian, Ebner Bernd, Stolte Dirk, Ibrahim Karim, Kolschmann Steffen, Strasser Ruth H., Schön Steffen, Broken heart syndrome: Tako Tsubo cardiomyopathy associated with an overdose of the serotonin–norepinephrine reuptake inhibitor Venlafaxine, 10.1016/j.euroneuro.2010.03.009
- Nanas Serafim, Sakellariou Dimitrios, Kapsimalakou Smaragda, Dimopoulos Stavros, Tassiou Antonia, Tasoulis Athanasios, Anastasiou-Nana Maria, Vagiakis Emmanouil, Roussos Charalampos, Heart Rate Recovery and Oxygen Kinetics After Exercise in Obstructive Sleep Apnea Syndrome, 10.1002/clc.20707
- Godkar Darshan, Stensby Jessica, Sinnapunayagam Selvaratnam, Niranjan Selva, Venlafaxine Induced Acute Myocardial Infarction With Normal Coronary Arteries : , 10.1097/mjt.0b013e31815b00a5
- WILSON A.D., HOWELL C., WARING W.S., VENLAFAXINE INGESTION IS ASSOCIATED WITH RHABDOMYOLYSIS IN ADULTS: A CASE SERIES, 10.2131/jts.32.97
- Mégarbane Bruno, Bloch Vanessa, Deye Nicolas, Baud Frédéric J., Pharmacokinetic/pharmacodynamic modelling of cardiac toxicity in venlafaxine overdose, 10.1007/s00134-006-0419-8
- McAlpine Donald E, Biernacka Joanna M, Mrazek David A, OʼKane Dennis J, Stevens Susanna R, Langman Loralie J, Courson Vicki L, Bhagia Jyoti, Moyer Thomas P, Effect of Cytochrome P450 Enzyme Polymorphisms on Pharmacokinetics of Venlafaxine : , 10.1097/ftd.0b013e3181fcf94d
- Kandasamy Mani, Srinivas P., Subramaniam Kala, Ravi Sandhya, John James, Shekar Radha, Srinivas Nuggehally, Thangam Saral, Differential outcomes from metabolic ratios in the identification of CYP2D6 phenotypes–focus on venlafaxine and O-desmethylvenlafaxine, 10.1007/s00228-010-0829-y
- Blythe David, Hackett L Peter, Cardiovascular and neurological toxicity of venlafaxine, 10.1191/096032799678840165
- Lessard ??tienne, Hamelin Bettina A., Labb?? Line, O??Hara Gilles, B??langer Pierre Maxime, Turgeon Jacques, Involvement of CYP2D6 activity in the N-oxidation of procainamide in man : , 10.1097/00008571-199912000-00003
- SIM S, RISINGER C, DAHL M, AKLILLU E, CHRISTENSEN M, BERTILSSON L, INGELMANSUNDBERG M, A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants, 10.1016/j.clpt.2005.10.002
Bibliographic reference | Vinetti, Marco ; Haufroid, Vincent ; Capron, Arnaud ; Classen, Jean-François ; Marchandise, Sébastien ; et. al. Severe acute cardiomyopathy associated with venlafaxine overdose and possible role of CYP2D6 and CYP2C19 polymorphisms.. In: Clinical Toxicology, Vol. 49, no. 9, p. 865-869 (2011) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/105874 |